why choose us

First received: May 26, 2023

Clinical Trial: Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chemotherapeutic Toxicity

Study Type: INTERVENTIONAL


Official Title: Strategy Therapy on Early Phase Cancer Therapeutics-Related Cardiac Dysfunction Patients

Brief Summary: The investigators use the cancer registration system of National Cheng Kung University Hospital to timely screen and evaluate those patients having breast cancer or lymphoma to enroll patients to participate in this clinical trial.The investigators planned an earlier initiation of Sacubitril/Valsartan treatment on breast cancer and lymphoma patients before the chemotherapy, and starting therapeutic intervention by Sacubitril/Valsartan once the heart damage sign appeared via novel echocardiography.The…

Read more